Innovation
-
Spotlight on India's freedom to innovate
Robust funding to startups and efforts to remove bureaucratic hurdles in government-owned research labs augur well for the future. But freedom to innovate has not been used to solve the most pressing social and economic problems
-
Promoting globalized innovation, bit by BIT
To create something truly novel, we need people with different backgrounds, knowledge and talents, people from different industries, to come together. That's why, ideally, innovation shouldn't be geographically constrained, says Darden professor
-
Has the NFT bubble already burst?
Non-fungible tokens shot to popularity earlier this year with headline-grabbing, multi-million-dollar sales of digital-only artworks. Globally, sales and token values have since fallen, while in India, NFT usage is slowly catching up. How much of it is hype and how much is here to stay?
-
Rallying innovation in the age of Covid-19
When it comes to innovations in the face of global pandemics, business as usual for our innovation system is unlikely to apply. There are strong pressures to make it freely available, and in the process, push down the return to any R&D that has been conducted
-
Special Briefing: Indegene CEO Manish Gupta talks about the next phase of digitalisation in pharma
From an ahead-of-its-times outfit to bring technology to 'medico marketing' to a multinational tech company offering AI and NLP platforms to the world's biggest drugmakers, Indegene has come a long way. The Covid-19 pandemic, however, showed that the Bengaluru company was only getting started. In this special briefing, Manish Gupta, co-founder and CEO of Indegene, recalls the early days of Indegene, and talks about what lies ahead
-
In 2021, consumers are craving products that deliver novelty and fun
After a year of buying boring staples in bulk, everything is about to change—and brands need to be ready to innovate
-
Drones centralise vaccine storage, reduce expensive refrigerated shipping: Zipline's Dan Czerwonka
Medical delivery firm Zipline has been working in Ghana and Rwanda to transport Covid-19 and other vaccines. Its head of global regulatory affairs Dan Czerwonka speaks about the advantages and challenges of deploying unmanned aircraft systems in other countries
-
How a clutch of startups is taking healthcare to rural India
Through innovation and pivots, these startups are helping rural India, which has little or no access to healthcare including, hospitals, doctors, diagnostics, or medicines, cope with the pandemic
-
India's pharma companies are readying 900 million doses of Sputnik V. Can it pull the country out of its Covid-19 mess?
Amid concerns surrounding Sputnik V and the launch of a single-dose vaccine, Indian companies, including Hetero, Stelis, Biopharma and Gland Pharma are on track to make millions of doses of the Russian vaccine in a bid to alleviate the country's supply constraints
-
Supporting long duration R&D programs to avoid time compression diseconomies
The first Covid-19 vaccine came in record time but it's easy to forget the decades of research into mRNA, which underpins the Pfizer-BioNTech vaccine
-
Industry 4.0: India's urgent need to make the revolution green
As millions are poured into digital transformation to survive the pandemic economy, augmenting sustainability alongside digital capabilities is an economic, competitive and global opportunity for India's businesses. But regulations need to reflect intent